Clarissa Sowemimo-Coker CEO: RNS R&D expansion into medical oncology

Video

19 Jul

Written By Rob Bennett

Rob Bennett https://www.oxcantech.com

Oxford Cannabinoid Technologies Takes Pain Drug into Phase I; Appoints Leading Pain Expert

Clarissa Sowemimo-Coker CEO: RNS MHRA clinical trial approval